疏肝利胆方干预胆色素结石模型豚鼠的作用机制研究

被引:6
作者
刘莹露
王玉娟
徐天舒
机构
[1] 南京大学医学院附属鼓楼医院
关键词
疏肝利胆方; 胆色素结石; 细胞因子; 调节免疫; 豚鼠;
D O I
暂无
中图分类号
R285.5 [中药实验药理]; R-332 [医用实验动物学];
学科分类号
100402 [劳动卫生与环境卫生学]; 100806 [中药药理学];
摘要
目的:探讨疏肝利胆方干预胆色素结石模型豚鼠的作用机制。方法:将15只豚鼠随机分为正常组、模型组及中药组,每组各5只。空白组和模型组每只豚鼠给予生理盐水1 m L·d-1灌胃,中药组给予疏肝利胆方灌胃。观察三组豚鼠成石率,并用酶联免疫吸附试验(EnzymeLinked Immuno Sorbent Assay,ELISA)测定豚鼠血清中白介素-15(Interleukin-15,IL-15)、IL-1β、IL-2、前列腺素E2(Prostaglandin E2,PGE2)及胆汁中IL-15、IL-2、C反应蛋白(C reactive protein,CRP)的含量。结果:中药组胆色素结石成石率较模型组明显下降,差异有统计学意义(P<0.05);与模型组比较,中药组中血清IL-15、IL-1β、PGE2的含量减少,IL-2的含量增加,差异均有统计学意义(P<0.05);与模型组比较,中药组胆汁IL-15、CRP的含量减少,IL-2的含量增加,差异具有统计学意义(P<0.05)。结论:疏肝利胆方可减少胆色素结石成石率,其治疗胆色素结石机制与下调某些促炎细胞因子、调节免疫机理有关。
引用
收藏
页码:417 / 420
页数:4
相关论文
共 31 条
[1]
[2]
Ocular Inflammatory Responses in the EP<sub>2</sub> and EP<sub>4</sub> Receptor Knockout Mice.[J].S. Biswas;P. Bhattacherjee;C. A. Paterson;S. L. Tilley;B. H. Koller.Ocular Immunology and Inflammation.2006, 3
[3]
Is a role of phospholipase A 2 in cholesterol gallstone formation phospholipid species-dependent?.[J].Yasushi Sunami;Susumu Tazuma;Kazuaki Chayama.BBA - Molecular and Cell Biology of Lipids.2001, 1
[4]
Pigment gallstone pathogenesis: Slime production by biliary bacteria is more important than beta-glucuronidase production [J].
Stewart, L ;
Ponce, R ;
Oesterle, AL ;
Griffiss, JM ;
Way, LW .
JOURNAL OF GASTROINTESTINAL SURGERY, 2000, 4 (05) :547-553
[5]
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment.[J].Dennis M. Willerford;Jianzhu Chen;Judith A. Ferry;Laurie Davidson;Averil Ma;Frederick W. Alt.Immunity.1995, 4
[6]
Composition of intrahepatic calculi.[J].Norio Yamashita;Jiro Yanagisawa;Fumio Nakayama.Digestive Diseases and Sciences.1988, 4
[7]
Pathogenesis of Calcium Bilirubinate Gallstone: Role of E. Coli; β-Glucuronidase and Coagulation by Inorganic Ions; Polyelectrolytes and Agitation.[J].TETSUO MAKI.Annals of Surgery.1966, 1
[8]
Prostaglandin receptors EP2; EP3; and IP mediate exudate formation in carrageenin-induced mouse pleurisy..Yuhki Koh-ichi;Ueno Akinori;Naraba Hiroaki;Kojima Fumiaki;Ushikubi Fumitaka;Narumiya Shuh;Oh-ishi Sachiko;.The Journal of pharmacology and experimental therapeutics.2004,
[9]
Fueling regulation: IL-2 keeps CD4+ Treg cells fit..Maloy Kevin J;Powrie Fiona;.Nature immunology.2005,
[10]
高敏C-反应蛋白与降钙素原对感染性疾病预后评估研究 [J].
杨欣悦 ;
钱传云 ;
樊楚明 .
中华医院感染学杂志, 2014, 24 (01) :22-24